Evidence map›Paper›PMID 37298055›Full record

ArticleJournal of clinical medicine2023

Evaluation of the Factors Associated with Reinfections towards SARS-CoV-2 Using a Case Control Design.

Giuseppe La Torre, Gianluca Paglione, Lavinia Camilla Barone, Vittoria Cammalleri, Augusto Faticoni, Mattia Marte, Roberta Noemi Pocino, Carlo Maria Previte, Andrea Bongiovanni, Corrado Colaprico and 16 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 1 institution in 1 country.

Giuseppe La TorreDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-1233-2040
Gianluca PaglioneDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Lavinia Camilla BaroneDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Vittoria CammalleriDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Augusto FaticoniDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Mattia MarteDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Roberta Noemi PocinoDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Carlo Maria PreviteDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Andrea BongiovanniDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Corrado ColapricoDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Eleonora RicciDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Valentin ImeshtariDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-2954-2095
Maria Vittoria ManaiDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
David ShaholliDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-0902-0302
Vanessa India BarlettaDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Giovanna CarluccioDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Luca MorettiDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Francesca VezzaDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Lorenzo VolpicelliDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-2610-8768
Anna Paola MassettiDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-0520-8743
Lilia CintiDepartment of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.
Piergiorgio RobertoDepartment of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-9170-3654
Anna NapoliDepartment of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.
Guido AntonelliDepartment of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.
Claudio Maria MastroianniDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-1286-467X
Sabina SerniaDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.
Sapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe risk of reinfection with SARS-CoV-2 has been rapidly increased with the circulation of concerns about variants. So, the aim of our study was to evaluate the factors that increase the risk of this reinfection in healthcare workers compared to those who have never been positive and those who have had only one positivity.

methodsA case-control study was carried out at the Teaching Hospital Policlinico Umberto I in Rome, Sapienza University of Rome, in the period between 6 March 2020 and 3 June 2022. Cases are healthcare workers who have developed a reinfection with the SARS-CoV-2 virus, while controls were either healthcare workers who tested positive once or those who have never tested positive for SARS-CoV-2.

results134 cases and 267 controls were recruited. Female gender is associated with a higher odds of developing reinfection (OR: 2.42; 95% CI: 1.38-4.25). Moreover, moderate or high alcohol consumption is associated with higher odds of reinfection (OR: 1.49; 95% CI: 1.19-1.87). Diabetes is also associated with higher odds of reinfection (OR: 3.45; 95% CI: 1.41-8.46). Finally, subjects with increased red blood cell counts have higher odds of reinfection (OR: 1.69; 95% CI: 1.21-2.25).

conclusionFrom the prevention point of view, these findings indicate that particular attention should be paid to subjects with diabetes mellitus, women and alcoholic drinkers. These results could also suggest that contact tracing represents a fundamental approach model against the SARS-CoV-2 pandemic, together with the health information of participants.

Indexed as

case-controlcontact tracingreinfectionsSARS-CoV-2

Identifiers

PMID37298055
PMCPMC10253296
OpenAlexW4379518892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.